Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

about

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure The underestimated danger of E-cigarettes - also in the absence of nicotine

P2860

Q41198115-7262EEDE-3F2A-47FA-A61C-01871AB368AA Q58696472-F92D10D0-F604-4254-8568-E7B923361E75

P2860

Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

Item

http://www.wikidata.org/entity/Q46424042

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Endothelin causes transactivat ...... -small cell lung cancer cells.

@en

Endothelin causes transactivat ...... -small cell lung cancer cells.

@nl

type

Item

label

Endothelin causes transactivat ...... -small cell lung cancer cells.

@en

Endothelin causes transactivat ...... -small cell lung cancer cells.

@nl

prefLabel

Endothelin causes transactivat ...... -small cell lung cancer cells.

@en

Endothelin causes transactivat ...... -small cell lung cancer cells.

@nl

P1476

Endothelin causes transactivat ...... -small cell lung cancer cells.

@en

P2093

David Wink

http://www.w3.org/2001/XMLSchema#string

Irene Ramos-Alvarez

http://www.w3.org/2001/XMLSchema#string

Lisa Ridnour

http://www.w3.org/2001/XMLSchema#string

Paula Moreno

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

Samuel A Mantey

http://www.w3.org/2001/XMLSchema#string

Terry W Moody

http://www.w3.org/2001/XMLSchema#string

P2860

The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade

Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor

Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

The endothelin axis: emerging role in cancer

Comprehensive molecular profiling of lung adenocarcinoma.

Lapatinib in the treatment of breast cancer

P304

90-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PEPTIDES.2017.01.012

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28153500

http://www.w3.org/2001/XMLSchema#string

P932

5421360

http://www.w3.org/2001/XMLSchema#string

Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

about

P2860

P2860

Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932